Type 2 diabetes is a complex, multifactorial disease, for which genetic and environmental
factors jointly determine susceptibility. Disentangling the genetic aetiology of Type 2 …

Despite numerous candidate gene and linkage studies, the field of type 2 diabetes (T2D)
genetics had until recently succeeded in identifying few genuine disease-susceptibility loci …

Type 2 diabetes is one of the most common complex diseases, of which considerable efforts
have been made to unravel the pathophysiological mechanisms. Recently, large‐scale …

Type 2 diabetes is a global pandemic for which there is currently no disease-modifying
treatment. New and targeted therapeutics are greatly needed, but progress in identifying …

The discovery of the association between HLA in the major histocompatibility complex
(MHC) on chromosome 6p21 with type 1 diabetes, but not with type 2 diabetes, suggested …

Genome‐wide association studies (GWAS) have facilitated a substantial and rapid increase
in the number of confirmed genetic susceptibility variants for complex diseases …

Type 2 diabetes mellitus has been at the forefront of human diseases and phenotypes
studied by new genetic analyses. Thanks to genome‐wide association studies, we have …

Genome-wide association study for type 2 diabetes: clinical... : Current Opinion in Lipidology
Genome-wide association study for type 2 diabetes: clinical applications : Current Opinion in …

As with other complex diseases, unbiased association studies followed by physiological and
experimental characterization have for years formed a paradigm for identifying genes or …

Type-2 diabetes is a complex disease modified by a number of environmental and genetic
factors that contribute at varying degrees to the final phenotype and possibly interact with …